Known targets — ChEMBL curated mechanism
AGTR1DHFRGABBR1GABBR2GABRA1GABRA2GABRA3GABRA4GABRA5GABRA6GABRB1GABRB2GABRB3GABRDGABREGABRG1GABRG2GABRG3GABRPGABRQGARTNR3C2PBP2XPTGS1PTGS2VKORC1blablaT-3blaT-4blaT-5blaT-6dacAdacBdacCfolAftsImrcAmrcBmrdApbp1apbp1bpbp2apbp2bpbp3polthyA
The experimentally established mechanism targets of Edetic Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.68 |
| ▸ | ALOX15 | P16050 | 2/20 | 0.68 |
| ▸ | MAPT | P10636 | 1/20 | 0.68 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.68 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.50 |
| ▸ | EYA2 | O00167 | 1/20 | 0.50 |
| ▸ | APP | P05067 | 1/20 | 0.50 |
| ▸ | ACE | P12821 | 1/20 | 0.50 |
| ▸ | BLM | P54132 | 2/20 | 0.48 |
| ▸ | PMP22 | Q01453 | 2/20 | 0.48 |
| ▸ | LMNA | P02545 | 1/20 | 0.48 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.48 |
| ▸ | ADRA2A | P08913 | 1/20 | 0.48 |
| ▸ | TSHR | P16473 | 1/20 | 0.48 |
| ▸ | DRD1 | P21728 | 1/20 | 0.48 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.48 |
| ▸ | SLC6A4 | P31645 | 1/20 | 0.48 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.48 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.48 |
| ▸ | DRD3 | P35462 | 1/20 | 0.48 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Edetic Acid SCHEMBL1809230 | 1.00 | KDM4E (0.68) | KDM4EALOX15MAPTSMN1; SMN2TDP1 | |
| Pentetic Acid SCHEMBL1821999 | 0.97 | KDM4E (0.73) | KDM4EALOX15MAPTSMN1; SMN2TDP1 | |
| Edetic Acid SCHEMBL7209785 | 0.97 | KDM4E (0.65) | KDM4EALOX15MAPTSMN1; SMN2TDP1 | |
| Edetic Acid SCHEMBL17159505 | 0.97 | KDM4E (0.73) | KDM4EALOX15MAPTSMN1; SMN2TDP1 | |
| Edetic Acid SCHEMBL20578139 | 0.97 | KDM4E (0.65) | KDM4EALOX15MAPTSMN1; SMN2TDP1 | |
| Edetic Acid SCHEMBL1512919 | 0.97 | KDM4E (0.65) | KDM4EALOX15MAPTSMN1; SMN2TDP1 | |
| Edetic Acid SCHEMBL857218 | 0.97 | KDM4E (0.65) | KDM4EALOX15MAPTSMN1; SMN2TDP1 | |
| Edetic Acid SCHEMBL3423511 | 0.97 | KDM4E (0.65) | KDM4EALOX15MAPTSMN1; SMN2TDP1 | |
| Edetic Acid SCHEMBL20578218 | 0.97 | KDM4E (0.65) | KDM4EALOX15MAPTSMN1; SMN2TDP1 | |
| Edetic Acid SCHEMBL14151785 | 0.97 | KDM4E (0.65) | KDM4EALOX15MAPTSMN1; SMN2TDP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 4915 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-122084499-A | Detection kit and detection method for abnormal lymphocyte, myeloid blast and acute promyelocytic leukemia | — | 2026-05-26 | — | — | CN | claimed |
| CN-121575082-A | Reagent composition for simultaneously stabilizing free DNA and free RNA in peripheral blood and application thereof | 厦门志煊生物科技有限公司 | 2026-02-27 | — | — | CN | claimed |
| EP-3997037-B1 | COMPOSITION USEFUL IN SULFATE SCALE REMOVAL | DORF KETAL CHEMICALS FZE (AE) | 2026-01-28 | — | — | EP | claimed |
| US-12484819-B2 | Syringe apparatus and methods | SIEMENS HEALTHCARE DIAGNOSTICS INC. (US) | 2025-12-02 | — | — | US | claimed |
| US-20250332118-A1 | NOVEL ORAL CARE FORMULATIONS FOR TREATMENT OF XEROSTOMIA | LIVIONEX INC (US) | 2025-10-30 | — | — | US | claimed |
| EP-4638677-A1 | CONTACT LENS TREATING SOLUTION | Bausch + Lomb Ireland Limited (IE) | 2025-10-29 | — | — | EP | claimed |
| EP-4637688-A1 | ORAL CARE COMPOSITIONS | Colgate-Palmolive Company (US) | 2025-10-29 | — | — | EP | claimed |
| US-20250320563-A1 | SAMPLE PREPARATION FOR CELL-FREE DNA ANALYSIS | NUCLEIX LTD. (IL) | 2025-10-16 | — | — | US | claimed |
| US-20250222110-A1 | METHODS AND COMPOSITIONS FOR TREATMENT OF AGE-RELATED CATARACTS | LIVIONEX INC (US) | 2025-07-10 | — | — | US | claimed |
| US-12350534-B2 | Extinguishant composition | YAMATO PROTEC CORPORATION (JP) | 2025-07-08 | — | — | US | claimed |
| US-4530781-A | Metastable prespotting composition | S. C. JOHNSON & SON, INC. (US) | 1985-07-23 | — | — | US | claimed |
| EP-0137474-A2 | Metastable prespotting composition | S.C. JOHNSON & SON, INC. (US) | 1985-04-17 | — | — | EP | claimed |
| EP-0137475-A2 | Aqueous laundry prespotting composition | S.C. JOHNSON & SON, INC. (US) | 1985-04-17 | — | — | EP | claimed |
| US-4344940-A | DERMATITIS | E. R. SQUIBB & SONS, INC. (US) | 1982-08-17 | — | — | US | claimed |
| US-4339340-A | HYDROXYLAKYL/TRIALKYLAMMONIUM HYDROXIDE | TOKYO SHIBAURA ELECTRIC CO., LTD. (JP) | 1982-07-13 | — | — | US | claimed |
| US-4259217-A | NONIONIC AND CATIONIC SURFACTANTS | THE PROCTER & GAMBLE COMPANY (US) | 1981-03-31 | — | — | US | claimed |
| US-4240920-A | A SURFACTANT, A PEROXY BLEACH AND A PORPHINE BLEACH | THE PROCTER & GAMBLE COMPANY (US) | 1980-12-23 | — | — | US | claimed |
| US-4239661-A | HYDROXYALKYL TRIALKYLAMMONIUM HYDROXIDE | TOKYO SHIBAURA ELECTRIC CO., LTD. (JP) | 1980-12-16 | — | — | US | claimed |
| US-3997348-A | FERRIC SALT BLEACHING SOLUTION | FUJI PHOTO FILM CO., LTD. (JA) | 1976-12-14 | — | — | US | claimed |
| US-3941723-A | Crystallized alkali metal silicate with sequestering agents | PHILADELPHIA QUARTZ COMPANY (US) | 1976-03-02 | — | — | US | claimed |